Bioage Labs Stock Technical Analysis
| BIOA Stock | 18.99 0.11 0.58% |
As of the 2nd of February, BioAge Labs shows the Downside Deviation of 3.45, mean deviation of 4.4, and Risk Adjusted Performance of 0.1896. BioAge Labs technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
BioAge Labs Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioAge, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioAgeBioAge Labs' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.BioAge Labs Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 12.0 | Hold | 4 | Odds |
Most BioAge analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BioAge stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of BioAge Labs, talking to its executives and customers, or listening to BioAge conference calls.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs. Projected growth potential of BioAge fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive BioAge Labs assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate BioAge Labs using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating BioAge Labs' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause BioAge Labs' market price to deviate significantly from intrinsic value.
It's important to distinguish between BioAge Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BioAge Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BioAge Labs' market price signifies the transaction level at which participants voluntarily complete trades.
BioAge Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioAge Labs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioAge Labs.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in BioAge Labs on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding BioAge Labs or generate 0.0% return on investment in BioAge Labs over 90 days. BioAge Labs is related to or competes with Lifecore Biomedical, Canopy Growth, Allogene Therapeutics, Editas Medicine, Alpha Teknova, Aurora Cannabis, and Atea Pharmaceuticals. BioAmber Inc., an industrial biotechnology company, produces and sells renewable chemicals worldwide More
BioAge Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioAge Labs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioAge Labs upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.45 | |||
| Information Ratio | 0.2427 | |||
| Maximum Drawdown | 33.5 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 13.88 |
BioAge Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioAge Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioAge Labs' standard deviation. In reality, there are many statistical measures that can use BioAge Labs historical prices to predict the future BioAge Labs' volatility.| Risk Adjusted Performance | 0.1896 | |||
| Jensen Alpha | 1.55 | |||
| Total Risk Alpha | 1.26 | |||
| Sortino Ratio | 0.4417 | |||
| Treynor Ratio | 5.08 |
BioAge Labs February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1896 | |||
| Market Risk Adjusted Performance | 5.09 | |||
| Mean Deviation | 4.4 | |||
| Semi Deviation | 2.63 | |||
| Downside Deviation | 3.45 | |||
| Coefficient Of Variation | 400.18 | |||
| Standard Deviation | 6.29 | |||
| Variance | 39.5 | |||
| Information Ratio | 0.2427 | |||
| Jensen Alpha | 1.55 | |||
| Total Risk Alpha | 1.26 | |||
| Sortino Ratio | 0.4417 | |||
| Treynor Ratio | 5.08 | |||
| Maximum Drawdown | 33.5 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 13.88 | |||
| Downside Variance | 11.93 | |||
| Semi Variance | 6.93 | |||
| Expected Short fall | (5.57) | |||
| Skewness | 1.85 | |||
| Kurtosis | 4.7 |
BioAge Labs Backtested Returns
BioAge Labs is somewhat reliable given 3 months investment horizon. BioAge Labs secures Sharpe Ratio (or Efficiency) of 0.27, which signifies that the company had a 0.27 % return per unit of risk over the last 3 months. We were able to break down and interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.73% are justified by taking the suggested risk. Use BioAge Labs Risk Adjusted Performance of 0.1896, mean deviation of 4.4, and Downside Deviation of 3.45 to evaluate company specific risk that cannot be diversified away. BioAge Labs holds a performance score of 21 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.31, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BioAge Labs' returns are expected to increase less than the market. However, during the bear market, the loss of holding BioAge Labs is expected to be smaller as well. Use BioAge Labs total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to analyze future returns on BioAge Labs.
Auto-correlation | 0.62 |
Good predictability
BioAge Labs has good predictability. Overlapping area represents the amount of predictability between BioAge Labs time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioAge Labs price movement. The serial correlation of 0.62 indicates that roughly 62.0% of current BioAge Labs price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.62 | |
| Spearman Rank Test | 0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 10.21 |
BioAge Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
BioAge Labs Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BioAge Labs volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About BioAge Labs Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BioAge Labs on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BioAge Labs based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BioAge Labs price pattern first instead of the macroeconomic environment surrounding BioAge Labs. By analyzing BioAge Labs's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioAge Labs's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioAge Labs specific price patterns or momentum indicators. Please read more on our technical analysis page.
BioAge Labs February 2, 2026 Technical Indicators
Most technical analysis of BioAge help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioAge from various momentum indicators to cycle indicators. When you analyze BioAge charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1896 | |||
| Market Risk Adjusted Performance | 5.09 | |||
| Mean Deviation | 4.4 | |||
| Semi Deviation | 2.63 | |||
| Downside Deviation | 3.45 | |||
| Coefficient Of Variation | 400.18 | |||
| Standard Deviation | 6.29 | |||
| Variance | 39.5 | |||
| Information Ratio | 0.2427 | |||
| Jensen Alpha | 1.55 | |||
| Total Risk Alpha | 1.26 | |||
| Sortino Ratio | 0.4417 | |||
| Treynor Ratio | 5.08 | |||
| Maximum Drawdown | 33.5 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 13.88 | |||
| Downside Variance | 11.93 | |||
| Semi Variance | 6.93 | |||
| Expected Short fall | (5.57) | |||
| Skewness | 1.85 | |||
| Kurtosis | 4.7 |
BioAge Labs February 2, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BioAge stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | (0.10) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 19.27 | ||
| Day Typical Price | 19.17 | ||
| Price Action Indicator | (0.33) | ||
| Market Facilitation Index | 1.13 |
Complementary Tools for BioAge Stock analysis
When running BioAge Labs' price analysis, check to measure BioAge Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAge Labs is operating at the current time. Most of BioAge Labs' value examination focuses on studying past and present price action to predict the probability of BioAge Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAge Labs' price. Additionally, you may evaluate how the addition of BioAge Labs to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |